InvestWiser

Navamedic ASA

NAVAOslo BørsHealthcareMarket value 248 m NOK
10.35NOK −3.3%
last day · Price as of 19 November 2026

The answer first

Does Navamedic beat the market?

No, Navamedic has not beaten the market over the last year.

Navamedic−51.9%Oslo Børs (OSEBX)+31.0%
  • The ranking · Quality, value and trend combined

    Better than 15% of Nordic stocks

    • Quality12
    • Value75
    • Trend8

    No. 147 of 195 in healthcare

  • Expectations in the price

    Moderate expectations

    For the share to return about 9% a year from today's price, the cash Navamedic keeps must grow about 6% a year for 10 years.

Max for seven days

Follow Navamedic with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Navamedic

From today, at a price of 10.35 NOK. Write why you follow Navamedic, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Navamedic

Your first answer is free, no account needed.

Do you own Navamedic, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Navamedic and a few more. Free, no card.

Past year against the exchange and Super Stock
Navamedic−51.9%Oslo Børs (OSEBX)+31.0%Super Stock+46.4%
18 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Navamedic has fallen 51.9% over the past year, including dividends.
  • Overall, Navamedic ranks better than 15% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 74.2%. The price is 75.7% below its peak now.

Who owns Navamedic? See the major shareholders and their stakes

What do analysts think of Navamedic?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

15

Quality, value and trend together. Better than 15% of Nordic stocks.

No. 147 of 195 in healthcare

Quality12
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 183 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.55
  • Asset turnoverSales divided by everything the company owns0.87
  • Return on equityProfit divided by equity−7.6%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value75
The price · Valuation: the multiples

High Low price: you pay little for what the company earns and owns.

No. 16 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity0.8
  • P/SPrice divided by sales0.4
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flow5.9

The ranking is built on P/E, P/B and P/S.

Trend8
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 161 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−30.8%
  • 6 months−41.7%
  • 9 months−51.6%
  • 12 months−51.9%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−20.4%
3 years, per year
−34.6%
5 years, per year
−16.8%
10 years, per year
−0.3%
Largest fall, 3 years
−74.2%
From a peak to the bottom
From the peak now
−75.7%
How far the price is from the peak
Volatility, 1 year
41.2%
How much the price swings over a year
Beta, 1 year
0.09
How much the price moves when the market moves

Return with dividends reinvested.

About Navamedic

Navamedic ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 38 employees.

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics.

See the full analysis of Navamedic.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Oslo Børs

Explore the stock market